title: Feeding behavior during long-term hexarelin administration in young and old rats.
abstract: Ghrelin, a 28-amino-acid peptide isolated from the stomach, is the natural ligand of the GH-secretagogues receptor-1a (GHS-R1a) and, so far, the only discovered circulating appetite-stimulating hormone. Similarly to ghrelin, many synthetic compounds belonging to the GHS family stimulate both GH secretion and feeding, whereas some stimulate GH secretion only. In the past years, studies have focused on the potential of the GHS to stimulate GH release during long-term treatment in humans and experimental animals. Few data are available about the extraendocrine effects of the GHS during several weeks of treatment, particularly in old rats. The aim of the present study was first to identify the lowest dose of hexarelin giving maximal stimulation of food intake both in young (3-month-old) and old rats (24-month-old). A dose-response study (80-320 microg/kg, s.c.) revealed that hexarelin at the dose of 80 microg/kg gave reproducibly maximal stimulation of food consumption in young as well as in old rats. Second, we evaluated the effect of 8-week daily sc treatment with hexarelin in young and old male rats. The outcome of the chronic study was that hexarelin (80 microg/kg, s.c., once daily) maintained a persistent significant orexigenic action throughout the treatment period, both in young and old rats. Interestingly, hexarelin treatment did not affect body weight gain either in young or old rats. We conclude that hexarelin is endowed with long-lasting orexigenic activity and might represent a potential therapeutic approach for pathological conditions characterized by a decline in food intake.
authors.affiliation: Department of Experimental Medicine, University of Milano-Bicocca, 20052 Monza, Italy. elena.bresciani@unimib.it
authors.forename: E
authors.initials: E
authors.lastname: Bresciani
authors.forename: N
authors.initials: N
authors.lastname: Pitsikas
authors.forename: L
authors.initials: L
authors.lastname: Tamiazzo
authors.forename: M
authors.initials: M
authors.lastname: Luoni
authors.forename: I
authors.initials: I
authors.lastname: Bulgarelli
authors.forename: D
authors.initials: D
authors.lastname: Cocchi
authors.forename: V
authors.initials: V
authors.lastname: Locatelli
authors.forename: A
authors.initials: A
authors.lastname: Torsello
mesh_terms: D000367:Age Factors; D000818:Animals; D001066:Appetite / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D004435:Eating / Q000187:drug effects*; D005247:Feeding Behavior / Q000187:drug effects*; D006133:Growth Substances / Q000494:pharmacology*; D008297:Male; D009842:Oligopeptides / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D015430:Weight Gain / Q000187:drug effects*
chemical_list: D006133:Growth Substances; D009842:Oligopeptides; C086184:hexarelin
references.citation: Circ Res. 2002 May 3;90(8):844-9
references.pmid: 11988484
references.citation: J Clin Endocrinol Metab. 1994 Mar;78(3):693-8
references.pmid: 8126144
references.citation: Endocrinology. 2004 Jan;145(1):234-42
references.pmid: 14551228
references.citation: Pharmacol Res. 1997 Jul;36(1):49-54
references.pmid: 9368914
references.citation: Am J Clin Nutr. 1997 Oct;66(4):760-73
references.pmid: 9322549
references.citation: Neurobiol Aging. 1993 Sep-Oct;14(5):503-7
references.pmid: 7902538
references.citation: Exp Gerontol. 2000 Dec;35(9-10):1251-65
references.pmid: 11113606
references.citation: Endocrinology. 1997 Nov;138(11):4552-7
references.pmid: 9348177
references.citation: Neuroendocrinology. 2005;81(5):339-49
references.pmid: 16210868
references.citation: J Clin Endocrinol Metab. 2001 Dec;86(12):5992
references.pmid: 11739476
references.citation: Endocrinology. 1999 Aug;140(8):3581-6
references.pmid: 10433214
references.citation: J Endocrinol. 2002 Aug;174(2):283-8
references.pmid: 12176667
references.citation: Endocrinology. 2000 Jun;141(6):2084-9
references.pmid: 10830294
references.citation: Endocr Rev. 2004 Jun;25(3):426-57
references.pmid: 15180951
references.citation: J Clin Invest. 2002 Jun;109(11):1429-36
references.pmid: 12045256
references.citation: Neuroendocrinology. 1998 Nov;68(5):312-8
references.pmid: 9822798
references.citation: J Gerontol A Biol Sci Med Sci. 1996 Nov;51(6):B439-47
references.pmid: 8914494
references.citation: Neuroendocrinology. 2000 Dec;72(6):327-32
references.pmid: 11146415
references.citation: Eur J Pharmacol. 1998 Nov 6;360(2-3):123-9
references.pmid: 9851578
references.citation: J Clin Endocrinol Metab. 1998 May;83(5):1644-9
references.pmid: 9589671
references.citation: Mol Endocrinol. 2006 Dec;20(12):3165-78
references.pmid: 16959872
references.citation: Neuroendocrinology. 1997 Feb;65(2):91-7
references.pmid: 9067986
references.citation: Eur J Endocrinol. 1999 Sep;141(3):313-20
references.pmid: 10474131
references.citation: Eur J Endocrinol. 1996 Oct;135(4):407-12
references.pmid: 8921821
references.citation: Endocrinology. 2000 Nov;141(11):4325-8
references.pmid: 11089570
references.citation: Aging (Milano). 1997;9(4 Suppl):19-20
references.pmid: 9358867
references.citation: J Neuroendocrinol. 2001 Jun;13(6):496-504
references.pmid: 11412336
references.citation: Biochem Biophys Res Commun. 2001 Jan 12;280(1):132-8
references.pmid: 11162489
references.citation: Clin Geriatr Med. 1995 Nov;11(4):661-74
references.pmid: 8556694
references.citation: Physiol Rev. 1999 Apr;79(2):511-607
references.pmid: 10221989
references.citation: Biochem Biophys Res Commun. 2000 Dec 29;279(3):909-13
references.pmid: 11162448
references.citation: Nature. 2000 Oct 19;407(6806):908-13
references.pmid: 11057670
references.citation: J Med Chem. 2000 Nov 16;43(23):4370-6
references.pmid: 11087562
references.citation: Diabetes. 2001 Nov;50(11):2540-7
references.pmid: 11679432
references.citation: Endocrinology. 2002 Feb;143(2):558-68
references.pmid: 11796511
references.citation: Gut. 2003 Jul;52(7):947-52
references.pmid: 12801949
references.citation: Endocrinology. 2007 Mar;148(3):1009-18
references.pmid: 17138655